Kelly A. Romano

CIK: 0001722055

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (77.8%)

Compensation grants

Other (G, F, J, C, D, …)2 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

LONA

LeonaBio, Inc.

Director

DORM

Dorman Products, Inc.

Director

UGI

UGI CORP /PA/

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

LONA
LeonaBio, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
DORM
Dorman Products, Inc.
Jun 1, 2026
Award(A)
Direct
1.3K shares at avg. $122.71$165K
DORM
Dorman Products, Inc.
May 15, 2026
Tax Payment(F)
Direct
33 shares at avg. $116.16$4K
LONA
LeonaBio, Inc.
Apr 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
UGI
UGI CORP /PA/
Jan 30, 2026
Award(A)
Indirect
4.4K shares-
DORM
Dorman Products, Inc.
Jun 2, 2025
Award(A)
Direct
1.1K shares-
ATHA
Athira Pharma, Inc.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20.9K shares-
DORM
Dorman Products, Inc.
May 16, 2025
Tax Payment(F)
Direct
46 shares at avg. $132.03$6K
UGI
UGI CORP /PA/
Jan 31, 2025
Award(A)
Indirect
5.7K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Jun 1, 2026	DORM Dorman Products, Inc.	Award(A)	1,344	$122.71	$164,922	Direct
May 15, 2026	DORM Dorman Products, Inc.	Tax Payment(F)	33	$116.16	$3,833	Direct
Apr 9, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Jan 30, 2026	UGI UGI CORP /PA/	Award(A)	4,364	-	$0	Indirect
Jun 2, 2025	DORM Dorman Products, Inc.	Award(A)	1,070	-	-	Direct
May 30, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	20,900	-	-	Direct
May 16, 2025	DORM Dorman Products, Inc.	Tax Payment(F)	46	$132.03	$6,073	Direct
Jan 31, 2025	UGI UGI CORP /PA/	Award(A)	5,695	-	-	Indirect

1-9 of 9 transactions

About Romano Kelly A

Romano Kelly A (SEC CIK 0001722055) files insider reports with the SEC as Director of LeonaBio, Inc. (LONA), Director of Dorman Products, Inc. (DORM) and Director of UGI CORP /PA/ (UGI).

Signal8 holds 9 ownership filings by Romano Kelly A, all Form 4s, filed between Feb 4, 2025 and Jun 24, 2026. Those filings report 9 transactions, from Jan 31, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Romano Kelly A's filings is in COLMAR, PA.

Recent filings by Romano Kelly A

Jun 23, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Jun 1, 2026: Grant or award of DORM shares (Form 4, code A).
May 15, 2026: Tax withholding of DORM shares (Form 4, code F).
Apr 9, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Jan 30, 2026: Grant or award of UGI shares (Form 4, code A).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes